
C-RAD Investor Relations Material
Latest events

Q2 2025
C-RAD
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from C-RAD
Access all reports
C-Rad AB, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer. The company offers its products under the C-Rad brand name. The company's endoMulti platform is a digital x-ray equipment with an ionizing radiation emitter and an advanced linac electronics module; and its endoDose platform includes linac platforms that are equipped with C-Rad's advanced dosimetry software. It also provides LINACsystems; and therapeutic linear accelerators and their subsystems. The company markets its products directly to customers through a global network of distributors. The company is based in Uppsala, Sweden.
Latest articles
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
Ticker symbol
CRAD
Country
🇸🇪 Sweden